---
title: "JXPCB: Plans to acquire 100% equity of Shenzhen Jiazhihong Electronics Co., Ltd., and the stock will resume trading tomorrow"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/235198721.md"
description: "JXPCB announced that the company intends to acquire 100% equity of Shenzhen Jiazhihong Electronics Co., Ltd. through the issuance of shares and cash payment, and to raise supporting funds. The company's stock will be suspended from trading starting March 27, 2025, and will resume trading on April 10, 2025. Given that the audit and evaluation work related to this transaction has not yet been completed, the board of directors has decided not to hold a shareholders' meeting to review this transaction at this time. The company will promptly announce the latest progress of this transaction"
datetime: "2025-04-09T10:27:10.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/235198721.md)
  - [en](https://longbridge.com/en/news/235198721.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/235198721.md)
---

# JXPCB: Plans to acquire 100% equity of Shenzhen Jiazhihong Electronics Co., Ltd., and the stock will resume trading tomorrow

JXPCB announced that the company intends to acquire 100% equity of Shenzhen Jiazhihong Electronics Co., Ltd. through the issuance of shares and cash payment, and to raise supporting funds. The company's stock will be suspended from trading starting March 27, 2025, and will resume trading on April 10, 2025. Given that the audit and evaluation work related to this transaction has not yet been completed, the board of directors has decided not to hold a shareholders' meeting to review this transaction at this time. The company will promptly announce the latest developments regarding this transaction

### Related Stocks

- [688655.CN](https://longbridge.com/en/quote/688655.CN.md)

## Related News & Research

- [Klick Health’s ‘18 Months’ Continues to Strike Gold With 29 Wins Alone During Creative Week](https://longbridge.com/en/news/287244265.md)
- [Orkla (OB:ORK) Margin Improvement Challenges Cautious Earnings Narratives Heading Into Q1 2026](https://longbridge.com/en/news/287134604.md)
- [Mabwell Wins Wider China Indications for Denosumab Biosimilar as Global Push Accelerates](https://longbridge.com/en/news/287103520.md)
- [BRIEF-Mexico's Fibra Next Extends, Raises Public Offer For Fibra Macquarie](https://longbridge.com/en/news/287128862.md)
- [Innovaccer Acquires CaduceusHealth to Make Revenue Cycle Autonomous](https://longbridge.com/en/news/287202119.md)